SEC Form 4 · accession 0000904454-15-000144
GENOCEA BIOSCIENCES, INC. · GNCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Katrine Bosley
Director
Period of report
Feb 26, 2015
Accepted (ET)
Mar 2, 2015 · 6:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001457612
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $9.08 | Feb 26, 2015 | A | 5,042 | A | — | Feb 25, 2025 | Common Stock | 5,042 | 5,042 | D |
Explanation of responses
- F1The option vests 100% on the first anniversary of the grant date.